SPH Notice – Andrew Raymond Mitchell

Disclosure of ceasing to have substantial holding
Section 279, Financial Markets Conduct Act 2013
To NZX Limited
and
To Promisia Healthcare Limited
Date this disclosure made:
Date last disclosure made:
Date on which substantial holding ceased:
1 December 2022
23 December 2021
1 December 2022
Substantial product holder(s) giving disclosure
Full name(s):
Summary of previous substantial holding
Class of quoted voting products:
Summary for
For last disclosure,—
(a) total number held in class:
(b) total in class:
(c) total percentage held in class:
Andrew Raymond Mitchell
Ordinary shares
Andrew Raymond Mitchell
1,497,102,561
21,284,975,154
7.033%
For current holding after ceasing to have substantial holding—
(a) total number held in class: 1,022,102,561
(b) total in class: 21,284,975,154
(c) total percentage held in class: 4.802%
Details of transactions and events giving rise to ceasing of substantial holding
Details of the transactions or other events
requiring disclosure:
Additional information
Address(es) of substantial product holder(s):
Off market sale of 475,000,000
shares on 1 December 2022 for
a total of $800,000 (being
$0.0016842 per share)
33 Sutherlands Road, Christchurch
Contact details: Andrew Mitchell, 027 692 1651
1

Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: Nil
Disclosure has effect for purposes of directors' and senior managers' disclosure:
Andrew Raymond Mitchell is also a director of Promisia Healthcare Limited. This
disclosure also constitutes disclosure for the purposes of the directors' and senior
managers' disclosure obligations.
Certification
I, Andrew Raymond Mitchell, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.
2